Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Genzyme Corporation v. Seikagaku Corporation, et al.
Case Number:
1:11-cv-10636
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 06, 2012
CORRECTED: Rival Drug Didn't Infringe Genzyme's Arthritis Patent: Jury
A federal jury in Massachusetts found Friday that drugmakers Seikagaku Corp. and Zimmer Inc. hadn't infringed Genzyme Corp.'s patent for osteoarthritis knee pain treatment Synvisc-One by marketing a rival pain treatment. (A previous version of this article incorrectly described Seikagaku's product as a generic drug.)
-
January 05, 2012
Genzyme Wins Restrictions On Generic Arthritis Drug Price
Genzyme Corp. has won a preliminary injunction in its infringement suit against Seikagaku Corp. over osteoarthritis knee pain treatment Synvisc-One, setting a minimum price at which the Japanese pharmaceutical maker can sell its lower-cost generic, Genzyme announced Thursday.
-
October 14, 2011
Pharma Co. Wants Ropes & Gray Atty Tossed From IP Suit
Seikagaku Corp. on Thursday asked a Massachusetts federal court to disqualify a Ropes & Gray LLP attorney representing Genzyme Corp. in its patent infringement suit against the Japanese pharmaceutical company, saying he will be called upon to testify in the trial.
-
October 04, 2011
Genzyme Gets Rival Pain Med Barred For Now In IP Row
A Massachusetts federal judge on Monday handed Genzyme Corp. a temporary restraining order in its patent infringement action against Seikagaku Corp. on Monday, temporarily barring sales of the Japanese pharmaceutical maker's Gel-One osteoarthritis knee pain treatment.
-
April 14, 2011
Genzyme Sues Seikagaku Over Synvisc-One Patent
Genzyme Corp. sued Seikagaku Corp. in Massachusetts on Thursday, claiming the Japanese pharmaceutical company's newly approved treatment for osteoarthritis knee pain infringes a patent for its knee pain relief treatment Synvisc-One.